Both stocks should deliver excellent returns to investors patient enough to hold through volatility. Equity markets started ...

Shares of DexCom Inc. DXCM rallied 3.79% to $73.38 Wednesday, on what proved to be an all-around positive trading session for ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Shares of DexCom Inc. slipped 9.15% to $70.72 Monday, on what proved to be an all-around poor trading session for the stock ...

DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

DexCom, Inc.'s (NASDAQ:DXCM) stock price has dropped 12% in the previous week, but insiders who sold US$16m in stock over the past year have had less luck. The average selling price of US$117 is ...

(NASDAQ:DXCM) stands against other best growth stocks ... to more than 5% in the US – 2022 was a bad year for the US stock market and especially growth stocks. However, 2023 brought in a whole ...

Hence, I have issued a sell rating on the stock. DXCM came up with its 4Q24 results earlier last month. The results were quite muted but were an improvement over even worse results in 3Q24.

While the company's stock has faced significant pressure following a disappointing second quarter in 2024, analysts remain cautiously optimistic about its future prospects, supported by DexCom's ...